Approach to Acute Myeloid Leukemia with Increased Eosinophils and Basophils
Preprint
- 12 January 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
There is remarkable morphologic and genetic heterogeneity in acute myeloid leukemia (AML). In a small percentage of cases of AML, increased eosinophils and/or basophils are present in the bone marrow and sometimes in the peripheral blood. This is often a puzzling diagnostic situation but also an important finding that requires special investigation. Unique chromosomal rearrangements have been correlated with an increased number of eosinophils and basophils in AML. Identification of the underlying genetic lesion that promotes eosinophilia and basophilia can dramatically change both the prognosis and the treatment of the patient. Thus clinicians must be vigilant in searching for the cause of eosinophilia and/or basophilia in patients with AML, since the different causes may lead to different treatments and survival outcomes. In this article we examine the significance of increased eosinophils and/or basophils in the context of AML, provide guidance that simplifies the differential diagnosis, and prognostic and therapeutic information about specific subtypes of AML associated with eosinophilia and/or basophilia. Evidence supporting personalized (molecularly targeted) therapy for these patients is also presented.Keywords
All Related Versions
- Version 1, 2024-01-12, Preprints
- Published version: Journal of Clinical Medicine, 13 (3), 876.
This publication has 70 references indexed in Scilit:
- Case of acute promyelocytic leukemia with basophilic differentiation and an ETV6 mutationJournal of Hematopathology, 2021
- World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2021
- Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genesAmerican Journal of Hematology, 2020
- Acute basophilic leukemia associated with the t(16;21)(p11;q22)/ FUS ‐ ERG fusion geneClinical Case Reports, 2017
- Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phaseAnnals of Hematology, 2017
- Endocrine manifestations of systemic mastocytosis in boneReviews in Endocrine and Metabolic Disorders, 2016
- Acute myeloid leukemia associated with FGFR1 abnormalitiesInternational Journal of Hematology, 2013
- Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotypingGenes, Chromosomes and Cancer, 2001
- Eosinophil infiltration and degranulation in normal human tissueThe Anatomical Record, 1998
- Acute basophilic leukemia in a child. Anaphylactoid reaction and coagulopathy secondary to vincristine-mediated degranulationCancer, 1995